Loading
What changed between revision 2 and revision 3, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 2
Import
Re-import of content/recoded-organisms.md — the file changed after the initial import. Not an edit.
13.6 kB
Revision 2
Revision 3
lines 8–14 → 8–147 unchanged lines not shown
categories: ["genetics"]categories: ["genetics"]tags: ["synthetic biology", "genetic code", "protein engineering", "biocontainment", "virus resistance"]tags: ["synthetic biology", "genetic code", "protein engineering", "biocontainment", "virus resistance"]summary: "Altering how a cell reads DNA so that reassigned codons encode amino acids not found in nature, producing organisms with chemistry and immunity no natural cell has."summary: "Altering how a cell reads DNA so that reassigned codons encode amino acids not found in nature, producing organisms with chemistry and immunity no natural cell has."updated: "2026-08-23"updated: "2026-10-29"humanEvidence: "No recoded mammal or person exists; genome recoding has been demonstrated only in bacteria, and the nearest contact with patients is investigational antibody conjugates built using non-standard amino acids."humanEvidence: "No recoded mammal or person exists; genome recoding has been demonstrated only in bacteria, and the nearest contact with patients is investigational antibody conjugates built using non-standard amino acids."access: "Not a clinical or consumer technology: recoded strains exist in a handful of academic laboratories, and the only products near patients are investigational antibody conjugates."access: "Not a clinical or consumer technology: recoded strains exist in a handful of academic laboratories, and the only products near patients are investigational antibody conjugates."reversibility: "irreversible"reversibility: "irreversible"lines 30–36 → 30–3615 unchanged lines not shown
}}`````` **Genetic code expansion and recoding** are two halves of one project: changing the rules by which a cell translates DNA into protein. Expansion adds a new amino acid to an organism's repertoire by assigning it a codon; recoding clears that codon first, by replacing every natural instance of it across the genome and deleting the machinery that reads it. The result is a cell that builds proteins from a chemistry unavailable to any natural organism — and, as a side effect that has proved at least as interesting, one that viruses cannot read.**Genetic code expansion and recoding** are two halves of one project: changing the rules by which a cell translates DNA into protein. Expansion adds a new amino acid to an organism's repertoire by assigning it a codon; recoding clears that codon first, by replacing every natural instance of it across the genome and deleting the machinery that reads it. The result is a cell that builds proteins from a chemistry unavailable to any natural organism, and, as a side effect that has proved at least as interesting, one that viruses cannot read. ## How it works## How it works lines 38–44 → 38–441 unchanged line not shown
### Orthogonal translation### Orthogonal translation Protein synthesis assigns amino acids to codons through aminoacyl-tRNA synthetases, each of which charges a particular transfer RNA with a particular amino acid. To add a twenty-first amino acid, an engineer supplies a synthetase–tRNA pair that ignores, and is ignored by, everything already in the cell — an **orthogonal pair**. The synthetase is then evolved in the laboratory to accept the desired non-standard amino acid, and the tRNA is given an anticodon matching whichever codon has been set aside.Protein synthesis assigns amino acids to codons through aminoacyl-tRNA synthetases, each of which charges a particular transfer RNA with a particular amino acid. To add a twenty-first amino acid, an engineer supplies a synthetase-tRNA pair that ignores, and is ignored by, everything already in the cell: an **orthogonal pair**. The synthetase is then evolved in the laboratory to accept the desired non-standard amino acid, and the tRNA is given an anticodon matching whichever codon has been set aside. The first such system, reported in 2001, used a pair borrowed from an archaeon and assigned a modified tyrosine to the amber stop codon.[^wang2001] The pair most used since derives from the pyrrolysine system of methanogenic archaea, which is orthogonal in bacterial, yeast and mammalian cells alike and tolerates an unusually wide range of substrates.The first such system, reported in 2001, used a pair borrowed from an archaeon and assigned a modified tyrosine to the amber stop codon.[^wang2001] The pair most used since derives from the pyrrolysine system of methanogenic archaea, which is orthogonal in bacterial, yeast and mammalian cells alike and tolerates an unusually wide range of substrates. lines 53–76 → 53–768 unchanged lines not shown
```timeline```timeline[[ { "year": "2001", "title": "First expanded code", "text": "Schultz's group incorporates a non-standard amino acid into a protein in living E. coli using an orthogonal synthetase–tRNA pair assigned to the amber codon." }, { "year": "2001", "title": "First expanded code", "text": "Schultz's group incorporates a non-standard amino acid into a protein in living E. coli using an orthogonal synthetase-tRNA pair assigned to the amber codon." }, { "year": "2010", "title": "Orthogonal ribosomes", "text": "Engineered ribosomes that read four-base codons allow multiple distinct non-standard amino acids to be encoded in one protein." }, { "year": "2010", "title": "Orthogonal ribosomes", "text": "Engineered ribosomes that read four-base codons allow multiple distinct non-standard amino acids to be encoded in one protein." }, { "year": "2013", "title": "First genomically recoded organism", "text": "All 321 amber codons are removed from the E. coli genome and the release factor deleted, giving efficient incorporation and partial phage resistance." }, { "year": "2013", "title": "First genomically recoded organism", "text": "All 321 amber codons are removed from the E. coli genome and the release factor deleted, giving efficient incorporation and partial phage resistance." }, { "year": "2015", "title": "Synthetic auxotrophy", "text": "Essential proteins are redesigned to require a synthetic amino acid, making the strain dependent on a compound available only in the laboratory." }, { "year": "2015", "title": "Synthetic auxotrophy", "text": "Essential proteins are redesigned to require a synthetic amino acid, making the strain dependent on a compound available only in the laboratory." }, { "year": "2019–2021", "title": "Three codons freed", "text": "A fully synthetic 4-megabase E. coli genome removes two serine codons and the amber codon; deleting the corresponding tRNAs yields broad resistance to bacteriophages." }, { "year": "2019-2021", "title": "Three codons freed", "text": "A fully synthetic 4-megabase E. coli genome removes two serine codons and the amber codon; deleting the corresponding tRNAs yields broad resistance to bacteriophages." }, { "year": "2023", "title": "Code swapping", "text": "Reassigning freed codons to new meanings is shown to block viral propagation and to prevent engineered genes from functioning if transferred to natural organisms." } { "year": "2023", "title": "Code swapping", "text": "Reassigning freed codons to new meanings is shown to block viral propagation and to prevent engineered genes from functioning if transferred to natural organisms." }]]`````` ## Current state## Current state Recoding at genome scale exists only in bacteria. Code expansion — adding one or two non-standard amino acids without clearing their codons — works routinely in yeast, in cultured mammalian cells, and in whole animals including mice, where it is used to make proteins that can be switched on with light or cross-linked to their binding partners on command. No recoded mammalian genome exists, and none is close: the recoding of a bacterial genome required total synthesis of four megabases, and a human genome is close to a thousand times that size.Recoding at genome scale exists only in bacteria. Code expansion, meaning one or two non-standard amino acids added without clearing their codons, works routinely in yeast, in cultured mammalian cells, and in whole animals including mice, where it is used to make proteins that can be switched on with light or cross-linked to their binding partners on command. No recoded mammalian genome exists, and none is close: the recoding of a bacterial genome required total synthesis of four megabases, and a human genome is close to a thousand times that size. > [!caution] The eukaryotic case is half a recoding> [!caution] The eukaryotic case is half a recoding> Yeast is where the two halves of recoding come apart, and it is worth stating which half is done. The Sc2.0 design changes every TAG stop codon in the genome to TAA, and all sixteen synthetic chromosomes have now been built to it,[^richardson2017] so the rewriting half exists in a eukaryote. The freeing half does not: eukaryotic release factor eRF1 reads all three stop codons, so it cannot be deleted the way bacterial RF1 was once its codon was cleared, and re-engineering it to ignore TAG remains a proposal.> Yeast is where the two halves of recoding come apart, one of them finished and the other not. The Sc2.0 design changes every TAG stop codon in the genome to TAA, and all sixteen synthetic chromosomes have now been built to it,[^richardson2017] so the rewriting half exists in a eukaryote. The freeing half does not: eukaryotic release factor eRF1 reads all three stop codons, so it cannot be deleted the way bacterial RF1 was once its codon was cleared, and re-engineering it to ignore TAG remains a proposal.> The chromosomes are also still in separate strains. The largest consolidated strain reported carries seven and a half of them, rather more than half the genome, and combining the rest into one cell is the project's stated open problem.[^zhao2023] Until that strain exists and its eRF1 is altered, genome-scale recoding in a eukaryote is a design that has been printed, not a code that has been changed.> The chromosomes are also still in separate strains. The largest consolidated strain reported carries seven and a half of them, rather more than half the genome, and combining the rest into one cell is the project's stated open problem.[^zhao2023] Until that strain exists and its eRF1 is altered, the eukaryotic project has printed a new design without yet changing the code. The commercial application that reached medicine first is protein conjugation. Placing a non-standard amino acid with a chemically distinct handle at a chosen position in an antibody allows a drug payload to be attached at exactly that site and nowhere else, giving a homogeneous product rather than the mixture produced by conventional chemistry. Antibody–drug conjugates built this way have advanced through clinical development, and the approach is now one of the more mature strands of [[targeted-drug-delivery]].The commercial application that reached medicine first is protein conjugation. Placing a non-standard amino acid with a chemically distinct handle at a chosen position in an antibody allows a drug payload to be attached at exactly that site and nowhere else, giving a homogeneous product rather than the mixture produced by conventional chemistry. Antibody-drug conjugates built this way have advanced through clinical development, and the approach is now one of the more mature strands of [[targeted-drug-delivery]]. ## Limitations## Limitations lines 82–94 → 82–945 unchanged lines not shown
The most developed safety application inverts the usual worry about engineered organisms. Rather than relying on physical containment, essential proteins in a recoded strain are redesigned so that they fold only when a synthetic amino acid is incorporated. The organism then cannot survive outside a laboratory that supplies the compound, and measured escape rates in the founding studies fell below the limit of detection.[^mandell2015] Code swapping adds a second layer: engineered genes written in a non-standard code are mistranslated if they are transferred horizontally into a natural organism, so the construct does not function even if the DNA escapes.[^nyerges2023]The most developed safety application inverts the usual worry about engineered organisms. Rather than relying on physical containment, essential proteins in a recoded strain are redesigned so that they fold only when a synthetic amino acid is incorporated. The organism then cannot survive outside a laboratory that supplies the compound, and measured escape rates in the founding studies fell below the limit of detection.[^mandell2015] Code swapping adds a second layer: engineered genes written in a non-standard code are mistranslated if they are transferred horizontally into a natural organism, so the construct does not function even if the DNA escapes.[^nyerges2023] These are the strongest existing demonstrations that engineered biology can be made intrinsically, rather than procedurally, contained — a contrast with the self-spreading elements described in [[gene-drive]], where containment is the unsolved problem. They remain laboratory results at modest scale, and no regulator currently treats synthetic auxotrophy as sufficient grounds for reduced physical containment.These are the strongest existing demonstrations that engineered biology can be made intrinsically, rather than procedurally, contained. The contrast is with the self-spreading elements described in [[gene-drive]], where containment is the unsolved problem. They remain laboratory results at modest scale, and no regulator currently treats synthetic auxotrophy as sufficient grounds for reduced physical containment. The risks run in the other direction too. A cell immune to all natural viruses is also a cell that natural ecosystems have no mechanism to control, which is one of the concerns that motivated the warnings collected in [[mirror-life]] about organisms placed outside the reach of existing biology. Recoding is discussed in [[dual-use-research]] assessments mainly as a capability multiplier rather than a direct hazard: the same synthesis and assembly infrastructure serves both, and the [[precautionary-principle]] arguments applied to genome writing apply here with the same force.The risks run in the other direction too. A cell immune to all natural viruses is also a cell that natural ecosystems have no mechanism to control, which is one of the concerns that motivated the warnings collected in [[mirror-life]] about organisms placed outside the reach of existing biology. Recoding is discussed in [[dual-use-research]] assessments mainly as a capability multiplier rather than a direct hazard: the same synthesis and assembly infrastructure serves both, and the [[precautionary-principle]] arguments applied to genome writing apply here with the same force. ## Outlook## Outlook Two goals define the near-term agenda. The first is bacterial: strains with several freed codons that can polymerise non-biological monomers, turning cells into programmable chemical factories for molecules the ribosome was never built to make. The second is mammalian, and much further off — a virus-resistant human cell line for biomanufacturing, proposed as the flagship of human genome writing, which would remove the contamination risk that shuts down production runs. A related and more tractable version of the same logic is already in clinical use in [[xenotransplantation]], where donor pigs have had endogenous retroviral sequences inactivated wholesale rather than recoded.Two goals define the near-term agenda. The first is bacterial: strains with several freed codons that can polymerise non-biological monomers, turning cells into programmable chemical factories for molecules the ribosome was never built to make. The second is mammalian and much further off: a virus-resistant human cell line for biomanufacturing, proposed as the flagship of human genome writing, which would remove the contamination risk that shuts down production runs. A related and more tractable version of the same logic is already in clinical use in [[xenotransplantation]], where donor pigs have had endogenous retroviral sequences inactivated wholesale rather than recoded. Whether recoding ever reaches a human organism rather than a human cell line is a separate question and not an active one. It would require rewriting every cell of a person, which means doing it at the embryo stage, and so falls squarely within the prohibitions on [[germline-editing]] surveyed in [[governance-of-genome-editing]]. The proposal occasionally surfaces in discussions of engineered virus immunity; nobody has proposed a credible route, and the mismatch between a laboratory strain that grows slowly on a defined medium and a functioning mammal is the reason.Whether recoding ever reaches a human organism rather than a human cell line is a separate question and not an active one. It would require rewriting every cell of a person, which means doing it at the embryo stage, and so falls squarely within the prohibitions on [[germline-editing]] surveyed in [[governance-of-genome-editing]]. The proposal occasionally surfaces in discussions of engineered virus immunity; nobody has proposed a credible route, and the mismatch between a laboratory strain that grows slowly on a defined medium and a functioning mammal is the reason. removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
105 lines are the same in both revisions, and 58 of them are not shown. Neither revision here is necessarily the current article — read Genetic code expansion and recoding for the text this wiki stands behind today.